Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Feb 15;130(4):663-669.
doi: 10.1242/jcs.195297.

Cancer cell behaviors mediated by dysregulated pH dynamics at a glance

Katharine A White  1 , Bree K Grillo-Hill  2 , Diane L Barber  3
Affiliations
Review

Cancer cell behaviors mediated by dysregulated pH dynamics at a glance

Katharine A White et al. J Cell Sci. .

Abstract

Dysregulated pH is a common characteristic of cancer cells, as they have an increased intracellular pH (pHi) and a decreased extracellular pH (pHe) compared with normal cells. Recent work has expanded our knowledge of how dysregulated pH dynamics influences cancer cell behaviors, including proliferation, metastasis, metabolic adaptation and tumorigenesis. Emerging data suggest that the dysregulated pH of cancers enables these specific cell behaviors by altering the structure and function of selective pH-sensitive proteins, termed pH sensors. Recent findings also show that, by blocking pHi increases, cancer cell behaviors can be attenuated. This suggests ion transporter inhibition as an effective therapeutic approach, either singly or in combination with targeted therapies. In this Cell Science at a Glance article and accompanying poster, we highlight the interconnected roles of dysregulated pH dynamics in cancer initiation, progression and adaptation.

Keywords: Cancer; Metabolism; Metastasis; Migration; Proliferation; pH.

PubMed Disclaimer

Conflict of interest statement

Competing interests

The authors declare no competing or financial interests.

References

    1. Alfarouk K. O., Stock C.-M., Taylor S., Walsh M., Muddathir A. K., Verduzco D., Bashir A. H. H., Mohammed O. Y., Elhassan G. O., Harguindey S. et al. (2015). Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp. Cancer Cell Int. 15, 71 10.1186/s12935-015-0221-1 - DOI - PMC - PubMed
    1. Amith S. R., Wilkinson J. M., Baksh S. and Fliegel L. (2015). The Na(+)/H(+) exchanger (NHE1) as a novel co-adjuvant target in paclitaxel therapy of triple-negative breast cancer cells. Oncotarget 6, 1262-1275. 10.18632/oncotarget.2860 - DOI - PMC - PubMed
    1. Amith S. R., Wilkinson J. M. and Fliegel L. (2016a). KR-33028, a potent inhibitor of the Na+/H+ exchanger NHE1, suppresses metastatic potential of triple-negative breast cancer cells. Biochem. Pharmacol. 118, 31-39. 10.1016/j.bcp.2016.08.010 - DOI - PubMed
    1. Amith S. R., Wilkinson J. M. and Fliegel L. (2016b). Na+/H+ exchanger NHE1 regulation modulates metastatic potential and epithelial-mesenchymal transition of triple-negative breast cancer cells. Oncotarget 7, 21091-21113. 10.18632/oncotarget.8520 - DOI - PMC - PubMed
    1. Andersen A. P., Moreira J. M. and Pedersen S. F. (2014). Interactions of ion transporters and channels with cancer cell metabolism and the tumour microenvironment. pHilos. Trans. R. Soc. Lond. B Biol. Sci. 369, 20130098 10.1098/rstb.2013.0098 - DOI - PMC - PubMed

Publication types